Cardio Diagnostics: Funding, Investors & Team (Sep 2026)
Cardio Diagnostics simplifies the process of preventing and detecting heart disease by providing customized and accurate solutions. ML/AI and DNA-based techniques are used by Cardio Diagnostics to revolutionize heart disease prevention. Cardio Diagnostics is located in Coralville, Iowa, United States and was established in 2017.
Cardio Diagnostics has raised $11.2M across 1 funding round on record, the most recent an undisclosed round of $11.2M announced in Mar 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cardio Diagnostics Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Cardio Diagnostics Funding Rounds
Cardio Diagnostics Founders and Leadership Team
Contact details for the Cardio Diagnostics team: 1 of 1 has an email address on file.
Start 14-day free trial →Cardio Diagnostics Funding Compared to Other Biotechnology Startups
Cardio Diagnostics' latest round of $11.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cardio Diagnostics in Biotechnology and Chicago
Companies Similar to Cardio Diagnostics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Cardio Diagnostics Funding FAQs
What does Cardio Diagnostics do?
Cardio Diagnostics simplifies the process of preventing and detecting heart disease by providing customized and accurate solutions. ML/AI and DNA-based techniques are used by Cardio Diagnostics to revolutionize heart disease prevention. Cardio Diagnostics is located in Coralville, Iowa, United States and was established in 2017.
How much funding has Cardio Diagnostics raised?
Cardio Diagnostics has raised $11.2M across 1 round on record. The most recent is an undisclosed round of $11.2M announced in Mar 2023.
When did Cardio Diagnostics last raise funding?
Cardio Diagnostics' most recent funding round on record is an undisclosed round of $11.2M, announced in Mar 2023.
Who is the CEO of Cardio Diagnostics?
Meesha Dogan is listed as CEO at Cardio Diagnostics.
Where is Cardio Diagnostics headquartered?
Cardio Diagnostics is based in Chicago, Illinois, United States.
How many employees does Cardio Diagnostics have?
Cardio Diagnostics is in the 1-10 employee band.
How does Cardio Diagnostics' funding compare to other Biotechnology startups?
Cardio Diagnostics' latest round of $11.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Cardio Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cardio Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.